RDY
Dr. Reddy’s Laboratories Ltd
12.90$
+2.7%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +64.8% | -47.8% | -16.2% | +59.2% | +4.0% | +19.6% | -21.3% | +109.5% | -22.8% | +2.2% | +22.0% | |
| – | +26.5% | +10.0% | +3.8% | +4.1% | +2.3% | +2.6% | -7.6% | +5.7% | +18.7% | +14.9% | +27.1% | |
| – | -5.4% | -15.5% | +14.1% | -14.3% | +33.9% | +12.1% | +1.4% | -32.9% | +2.5% | +4.2% | -23.1% | |
| – | +1,712,989,907.7% | -68.6% | -104.9% | – | – | +122.8% | -45.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.9% | +175.5% | -73.1% | -32.2% | -18.4% | +105.4% | +51.7% | -1.0% | +45.4% | +25.4% | -28.6% | |
| – | -10.8% | -9.6% | -19.4% | -48.1% | -36.3% | +360.3% | +16.4% | +56.8% | -2.6% | +44.2% | +21.4% | |
| – | +33.9% | -17.4% | +17.8% | +0.3% | -2.1% | +5.9% | 0.0% | +20.1% | +33.5% | +0.2% | +5.2% | |
| – | -100.0% | -1,569,500.0% | – | -4,215.4% | -11.4% | +151.7% | – | +10.2% | +118.8% | -272.5% | -100.0% | |
| – | -51,236,099,330.1% | – | -94.6% | -1,821.3% | +26.2% | – | -55.1% | -845.8% | – | +433.7% | -18.1% | |
| – | +312.8% | -78.3% | +20.3% | +380.3% | +18.0% | -98.8% | +712.8% | +1,009.0% | -86.0% | – | -29.2% | |
| – | – | – | – | – | – | – | -99.8% | -28,453.1% | – | +463.7% | -111.7% | |
| – | +171.7% | -173.8% | – | +203.7% | +11.8% | -2.5% | -60.9% | +341.6% | -55.0% | -33.2% | +166.8% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.